SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010806
Filing Date
2019-11-12
Accepted
2019-11-12 16:13:20
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20190930x10q942bc6.htm   iXBRL 10-Q 1133558
2 EX-10.1 ex-10d1.htm EX-10.1 276356
3 EX-31.1 ex-31d1.htm EX-31.1 13485
4 EX-31.2 ex-31d2.htm EX-31.2 15499
5 EX-32.1 ex-32d1.htm EX-32.1 10590
6 EX-32.2 ex-32d2.htm EX-32.2 8670
7 GRAPHIC ex-10d1g001.jpg GRAPHIC 2043
8 GRAPHIC omer-20190930x10q942bc6006.jpg GRAPHIC 32002
  Complete submission text file 0001558370-19-010806.txt   5984705

Data Files

Seq Description Document Type Size
9 EX-101.SCH omer-20190930.xsd EX-101.SCH 33561
10 EX-101.CAL omer-20190930_cal.xml EX-101.CAL 59053
11 EX-101.DEF omer-20190930_def.xml EX-101.DEF 106563
12 EX-101.LAB omer-20190930_lab.xml EX-101.LAB 379139
13 EX-101.PRE omer-20190930_pre.xml EX-101.PRE 266271
32 EXTRACTED XBRL INSTANCE DOCUMENT omer-20190930x10q942bc6_htm.xml XML 1158931
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 191209550
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences